Table 2.
Quantity | Dosimetry objective | No. of studies assessed this quantity |
---|---|---|
Fluoroscopy time* | Quality assurance | 60 |
Dose Area Product (DAP)† | Quality assurance | 53 |
Cine frames* | Quality assurance | 27 |
Effective dose† | Stochastic risk | 23 |
Cine time* | Quality assurance | 12 |
Skin dose† | Deterministic risk | 12 |
Coronary dose‡† | Deterministic risk | 2 |
non-dosimetric
dosimetric
dose to a coronary artery (in Gy) measured with a catheter based dosimeter during irradiation